Executive Summary
The Medical Technologies & Business Development consulting office of Dr. Dov Maor is based on over 20 years of experience in the high-tech industry, especially in the electronics and physics based medical devices sector. During this time Dr. Maor has acquired experience in all aspects of the business from idea to full-blown marketing and sales. Special expertise has been acquired in Intellectual Property matters including management of large patent portfolios and leading two successful patents lawsuits in the US.
The office provides consultation at all stages of the development of a high-tech enterprise. At inception, evaluation of technological feasibility and market potential, competition analysis and setting up an R&D plan are offered. During product development managerial support is available, including identification, recruitment and management of beta sites. Clients can make use of the vast experience in successful submissions to R&D financing bodies such as the Office of the Chief Scientist of the Ministry of Industry and Trade, Binational Foundations, EU Framework Programmes and diverse awards (won several prizes including the EU IST Grand Prize). For medical device enterprises, planning and management of clinical trials as well as obtaining regulatory approvals (FDA, CE and others) are additional available services.
As the product approaches readiness, education of the market, especially in the case of very novel products, is a very important factor in product introduction. Identifying key opinion leaders and making presentations at their institutions and at professional conferences is a particular area of considerable expertise. From here on consultation is provided on going to market, with special emphasis on the diverse European markets, including the former Soviet Union countries.
Management of the Intellectual Property at all stages is offered also as a separate service. This includes development of patenting strategy, management of the patenting process and patents portfolio, analysis of competitive IP, licensing and litigation.
|